The Clinical Dermatology MSc is an advanced study programme aimed at medical graduates wishing to specialise in the field of dermatology. You will gain advanced practical training in laboratory sciences relevant to skin disease, and enhance your skills and knowledge of the scientific basis of clinical dermatology. The study pathway also includes a critical evaluation of dermatological literature on a specialist subject.
The Clinical Dermatology MSc will provide you with the opportunities to develop and demonstrate a comprehensive knowledge and understanding of dermatological diseases.
Located within the St John's Institute of Dermatology, a specialised clinical, teaching and research institute based in Guy's and St Thomas' hospitals, the course has full access to academic facilities including a lecture room, study areas and teaching laboratory.
The study pathway is made up of a combination of clinical sessions, lectures, seminars and conferences by members of the faculty as well as invited prominent speakers, creating a demanding and stimulating learning experience.
You will study three 60-credit modules throughout the year including theoretical dermatology and clinical dermatology, plus a research project with a dissertation related to clinical dermatology to complete the 180-credit advanced course.
You will be taught through a combination of lectures, seminars and self study.
The primary method of assessment for this course is a combination of essay writing, course work in the form of a clinical Poweroint presentation, pathology slide reading at the microscope, clinical and theoretical OSCEs and a written dissertation and its defence.
This course is primarily taught at the King’s College London Guy’s and St Thomas’ campuses.
King’s College is regulated by the Higher Education Funding Council for England.
Our graduates have found employment in senior hospital posts and private practice overseas. Some of our graduates have pursued further higher qualifications and Foundation Programmes in the UK.
This online programme will give you a comprehensive understanding of the processes, investigation procedures and treatment options for common diseases you encounter in general medical practice.
The programme is mostly for early postgraduate doctors. It complements the learning you need to achieve membership of the Royal College of Physicians and it may also be suitable for doctors in other specialties, or nurse consultants and other paramedical specialists with extensive clinical experience.
We cover basic physiology, pathophysiology, therapy and clinical management, as well as clinical skills, generic skills (including writing and research methods) law, ethics and prescribing ability.
Problem-based learning through clinical case scenarios will be used to enhance knowledge and clinical decision-making. We use a variety of e-learning resources and platforms, including a virtual classroom with online tutorials and lectures, online interactive resources and virtual patients.
Our online learning technology is fully interactive, award-winning and enables you to communicate with our highly qualified teaching staff from the comfort of your own home or workplace. Students not only have access to Edinburgh’s excellent resources, but also become part of a supportive online community, bringing together students and tutors from around the world.
This programme is made up of compulsory and optional courses.
Further programme information
This programme is designed to help medical professionals gain the next step in their medical career, with a highly regarded qualification and first-rate expertise.
We invite postgraduate research proposals in a number of disease areas that impact significantly on patient care. We focus on exploring the mechanisms of disease, understanding the ways disease impacts patients’ lives, utilising new diagnostic and therapeutic techniques and developing new treatments.
As a student you will be registered with a University research institute, for many this is the Institute for Cellular Medicine (ICM). You will be supported in your studies through a structured programme of supervision and training via our Faculty of Medical Sciences Graduate School.
We undertake the following areas of research and offer MPhil, PhD and MD supervision in:
Newcastle hosts one of the most comprehensive organ transplant programmes in the world. This clinical expertise has developed in parallel with the applied immunobiology and transplantation research group. We are investigating aspects of the immunology of autoimmune diseases and cancer therapy, in addition to transplant rejection. We have themes to understand the interplay of the inflammatory and anti-inflammatory responses by a variety of pathways, and how these can be manipulated for therapeutic purposes. Further research theme focusses on primary immunodeficiency diseases.
There is strong emphasis on the integration of clinical investigation with basic science. Our research include:
We also research the effects of UVR on the skin including mitochondrial DNA damage as a UV biomarker.
This area emphasises on translational research, linking clinical- and laboratory-based science. Key research include:
Focus is on applied research and aims to underpin future clinical applications. Technology-oriented and demand-driven research is conducted which relates directly to health priority areas such as:
This research is sustained through extensive internal and external collaborations with leading UK and European academic and industrial groups, and has the ultimate goal of deploying next-generation diagnostic and therapeutic systems in the hospital and health-care environment.
There is a number of research programmes into the genetics, immunology and physiology of kidney disease and kidney transplantation. We maintain close links between basic scientists and clinicians with many translational programmes of work, from the laboratory to first-in-man and phase III clinical trials. Specific areas:
We have particular interests in:
Novel non-invasive methodologies using magnetic resonance are developed and applied to clinical research. Our research falls into two categories:
Our studies cover a broad range of topics (including diabetes, dementia, neuroscience, hepatology, cardiovascular, neuromuscular disease, metabolism, and respiratory research projects), but have a common theme of MR technical development and its application to clinical research.
We focus on connective tissue diseases in three, overlapping research programmes. These programmes aim to understand:
This research theme links with other local, national and international centres of excellence and has close integration of basic and clinical researchers and hosts the only immunotherapy centre in the UK.
Genetic approaches to the individualisation of drug therapy, including anticoagulants and anti-cancer drugs, and in the genetics of diverse non-Mendelian diseases, from diabetes to periodontal disease, are a focus. A wide range of knowledge and experience in both genetics and clinical sciences is utilised, with access to high-throughput genotyping platforms.
Our scientists and clinicians use in situ cellular technologies and large-scale gene expression profiling to study the normal and pathophysiological remodelling of vascular and uteroplacental tissues. Novel approaches to cellular interactions have been developed using a unique human tissue resource. Our research themes include:
We also have preclinical molecular biology projects in breast cancer research.
We conduct a broad range of research activities into acute and chronic lung diseases. As well as scientific studies into disease mechanisms, there is particular interest in translational medicine approaches to lung disease, studying human lung tissue and cells to explore potential for new treatments. Our current areas of research include:
Our research projects are concerned with the harmful effects of chemicals, including prescribed drugs, and finding ways to prevent and minimise these effects. We are attempting to measure the effects of fairly small amounts of chemicals, to provide ways of giving early warning of the start of harmful effects. We also study the adverse side-effects of medicines, including how conditions such as liver disease and heart disease can develop in people taking medicines for completely different medical conditions. Our current interests include: environmental chemicals and organophosphate pesticides, warfarin, psychiatric drugs and anti-cancer drugs.
Our new School of Pharmacy has scientists and clinicians working together on all aspects of pharmaceutical sciences and clinical pharmacy.
Advanced Practice is a part-time programme for experienced healthcare practitioners in hospital and community settings. The programme builds on your existing skills and experience to enable you to lead and support the development and delivery of evidence-based practice. Module outcomes are mapped against the Knowledge and Skills Framework so NHS employees can identify learning to support career progression.
This programme is suitable for practitioners, educators and managers from many healthcare disciplines who are developing autonomous practice, supporting educational and practice development or exercising clinical leadership. Practitioners may choose to follow a generic pathway or choose from a number of clinical specialities. Applicants are generally expected to be working within the chosen specialist field.
The programme is relevant for qualified healthcare practitioners in the following areas or roles: Cancer Nursing, Cardiac Care, Child Healthcare, Critical Care, Dermatology, Diabetes Care, District Nursing, Leadership, Midwifery, Palliative Care, Primary Care Nurse Practitioner/Community Matron/Case Manager, Women's Health Care.
Modules will only run if there are sufficient numbers of students enrolled and the minimum number is 12.
This programme is intended for experienced healthcare practitioners who are seeking to advance their practice, enhance their knowledge of research and evidence-based healthcare, and develop their roles.
This programme is part-time with taught sessions comprising a mixture of one day per week attendance and study blocks. Students select from modules rated at 15 or 30 credits. Students may elect to undertake one or more practice portfolios where practice accounts are used to demonstrate specialist or advanced practice.
Students are assessed through a combination of coursework and examinations. This can include written assignments such as essays, portfolios and dissertations. In addition, some modules will require students to undertake a presentation as part of the module assessment. A small number of modules are assessed by an exam, such as an unseen written examination or a computer-based assessment.
All students will also have to complete a clinical-based competency assessment as part of the MSc/PGDip/PGCert Advanced Practice pathway. This assessment is a clinical hurdle with 0 credits and is undertaken in the student’s workplace with an assessor.
Possible options after taking this programme include advanced practice roles such as nurse consultant, specialist practice roles, education, research and audit.